AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
ATXN2 |
Q99700
|
ataxin 2
|
Nucleic acid binding
|
0.85 |
0.482 |
0.808 |
BRD3 |
Q15059
|
bromodomain containing 3
|
Epigenetic regulator
|
0.97 |
0.700 |
0.500 |
C11orf65 |
Q8NCR3
|
chromosome 11 open reading frame 65
|
|
2.0E-14 |
0.670 |
0.462 |
C18orf25 |
Q96B23
|
chromosome 18 open reading frame 25
|
|
0.89 |
0.931 |
0.231 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
CPNE4 |
Q96A23
|
copine 4
|
|
8.6E-02 |
0.861 |
0.192 |
FAM234A |
Q9H0X4
|
family with sequence similarity 234 member A
|
|
1.5E-12 |
1.000 |
0.077 |
GFI1B |
Q5VTD9
|
growth factor independent 1B transcriptional repressor
|
|
5.2E-04 |
0.623 |
0.500 |
HBS1L |
Q9Y450
|
HBS1 like translational GTPase
|
Enzyme
|
1.9E-07 |
0.705 |
0.462 |
IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |
LEPR |
P48357
|
leptin receptor
|
Signaling
|
0.99 |
0.433 |
0.808 |
LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
LY75 |
O60449
|
lymphocyte antigen 75
|
|
7.4E-46 |
0.670 |
0.538 |
LY75-CD302 |
O60449
|
LY75-CD302 readthrough
|
|
7.4E-46 |
0.711 |
0.423 |
NDFIP1 |
Q9BT67
|
Nedd4 family interacting protein 1
|
|
0.98 |
0.716 |
0.462 |
NLRP3 |
Q96P20
|
NLR family pyrin domain containing 3
|
|
8.1E-04 |
0.361 |
0.962 |
PIK3R3 |
Q92569
|
phosphoinositide-3-kinase regulatory subunit 3
|
Enzyme modulator
|
3.4E-10 |
0.556 |
0.692 |
PXYLP1 |
Q8TE99
|
2-phosphoxylose phosphatase 1
|
Enzyme
|
3.1E-03 |
1.000 |
0.038 |
RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
RASA2 |
Q15283
|
RAS p21 protein activator 2
|
Enzyme modulator
|
7.4E-31 |
0.579 |
0.769 |
RBPMS |
Q93062
|
RNA binding protein, mRNA processing factor
|
Nucleic acid binding
|
0.97 |
0.780 |
0.423 |